首页> 外文期刊>Journal of endocrinological investigation. >A nomogram and risk classification system for predicting cancer-specific survival in tall cell variant of papillary thyroid cancer: a SEER-based study
【24h】

A nomogram and risk classification system for predicting cancer-specific survival in tall cell variant of papillary thyroid cancer: a SEER-based study

机译:用于预测甲状腺状癌高细胞变异型癌症特异性生存期的列线图和风险分类系统:一项基于 SEER 的研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background Tall cell variant (TCV) of papillary thyroid cancer (PTC) is the most common aggressive subtype of PTC. The factors that affect survival of patients with TCV remain unclear. We aimed to develop a model to predict the cancer-specific survival (CSS). Methods A total of 1615 patients diagnosed with TCV between 2004 and 2016 were identified from the Surveillance, Epidemiology, and End Results (SEER) database and randomized into training and validation cohorts (7:3). A predictive nomogram for predicting CSS was constructed by Cox proportional hazards regression and validated by concordance index (C-index), calibration curve, and decision curve analyses (DCA). A risk classification system was built based on the total nomogram scores of each case. Results A nomogram was constructed including five independent prognostic factors (age, tumor size, T stage, M stage, and extent of surgery) associated with CSS in TCV patients. Various validations proved that the nomogram model had good consistency and discrimination for TCV prognosis. The risk classification system could perfectly classify TCV patients into three risk groups with significantly different CSS. Compared with traditional AJCC TNM staging system, the nomogram could better predict CSS in TCV patients. Conclusions A nomogram and corresponding risk classification system were developed for predicting CSS in TCV patients. The model has excellent performance and can be used to help clinicians make accurate prognostic assessment and individualized treatment.
机译:背景 甲状腺状癌 (PTC) 的高大细胞变异 (TCV) 是 PTC 最常见的侵袭性亚型。影响TCV患者生存的因素尚不清楚。我们旨在开发一个模型来预测癌症特异性生存期 (CSS)。方法 从监测、流行病学和最终结果 (SEER) 数据库中确定了 2004 年至 2016 年间诊断为 TCV 的 1615 例患者,并随机分为训练组和验证组 (7:3)。采用Cox比例风险回归构建预测CSS的预测列线图,并通过一致性指数(C指数)、校准曲线和决策曲线分析(DCA)进行验证。根据每个病例的列线图总分构建风险分类系统。结果 构建了TCV患者CSS相关5个独立预后因素(年龄、肿瘤大小、T分期、M分期和手术范围)列线图。各种验证证明,列线图模型对TCV预后具有较好的一致性和鉴别力。风险分类系统能够将TCV患者完美地分为3个CSS差异显著的风险组。与传统的AJCC TNM分期系统相比,列线图能更好地预测TCV患者的CSS。结论 建立了TCV患者CSS的列线图及相应的风险分类系统。该模型具有优异的性能,可用于帮助临床医生进行准确的预后评估和个体化治疗。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号